findmyKOL
Clinical trialNCT02979249CompletedInterventional

Oral Iron for Erythropoietic Protoporphyrias

SponsorIcahn School of Medicine at Mount SinaiEnrollment16EPPErythropoietic ProtoporphyriaX-linked ProtoporphyriaXLP
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama, Birmingham

    Birmingham, Alabama, United States

  • University of California

    San Francisco, California, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Iron
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2016
Primary completion
19 Jul 2019
Completion
19 Jul 2019
Last update posted
11 Sept 2020
Registered enrollment
16
Registry id
NCT02979249

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.